Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Somaxon Pharmaceuticals, Inc. (SOMX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Somaxon Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1339455.
Total stock buying since 2010: $34,666.
Total stock sales since 2010: $3,102,456.
Total stock option exercises since 2010: $28,290.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2013 | 0 | $0 | 412 | $1,268 | 0 | $0 |
| 2012 | 0 | $0 | 6,754,769 | $2,040,950 | 0 | $0 |
| 2011 | 11,100 | $24,941 | 64,415 | $175,963 | 0 | $0 |
| 2010 | 2,500 | $9,725 | 295,916 | $884,275 | 23,000 | $28,290 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2013-01 | 0 | $0 | 412 | $1,268 | 0 | $0 |
| 2012-09 | 0 | $0 | 1,367 | $396 | 0 | $0 |
| 2012-07 | 0 | $0 | 4,948,698 | $1,491,697 | 0 | $0 |
| 2012-06 | 0 | $0 | 141,810 | $41,120 | 0 | $0 |
| 2012-05 | 0 | $0 | 1,622,844 | $488,634 | 0 | $0 |
| 2012-01 | 0 | $0 | 40,050 | $19,103 | 0 | $0 |
| 2011-10 | 0 | $0 | 5,000 | $4,260 | 0 | $0 |
| 2011-08 | 0 | $0 | 5,000 | $5,560 | 0 | $0 |
| 2011-07 | 0 | $0 | 5,000 | $10,634 | 0 | $0 |
| 2011-06 | 11,100 | $24,941 | 0 | $0 | 0 | $0 |
| 2011-05 | 0 | $0 | 5,000 | $13,245 | 0 | $0 |
| 2011-04 | 0 | $0 | 8,300 | $23,423 | 0 | $0 |
| 2011-02 | 0 | $0 | 10,000 | $30,099 | 0 | $0 |
| 2011-01 | 0 | $0 | 26,115 | $88,742 | 0 | $0 |
| 2010-12 | 0 | $0 | 246,634 | $664,378 | 0 | $0 |
| 2010-09 | 2,500 | $9,725 | 14,282 | $60,610 | 3,000 | $3,690 |
| 2010-08 | 0 | $0 | 8,000 | $36,920 | 8,000 | $9,840 |
| 2010-07 | 0 | $0 | 3,000 | $11,970 | 3,000 | $3,690 |
| 2010-06 | 0 | $0 | 24,000 | $110,397 | 9,000 | $11,070 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-01-02 | Nguyen Tran (SVP and CFO) | Sale | 412 | 3.08 | 1,268 |
| 2012-09-05 | Emster Kurt Von (Director) | Sale | 1,367 | .29 | 396 |
| 2012-07-09 | Mpm Bioventures Iii Gp L.p. (10% Owner) | Sale | 1,624,574 | .31 | 498,744 |
| 2012-07-09 | Gadicke Ansbert (10% Owner) | Sale | 1,624,574 | .31 | 498,744 |
| 2012-07-06 | Mpm Bioventures Iii Gp L.p. (10% Owner) | Sale | 671,217 | .29 | 195,324 |
| 2012-07-06 | Gadicke Ansbert (10% Owner) | Sale | 671,217 | .29 | 195,324 |
| 2012-07-03 | Gadicke Ansbert (10% Owner) | Sale | 98,210 | .29 | 28,480 |
| 2012-07-02 | Mpm Bioventures Iii Gp L.p. (10% Owner) | Sale | 178,558 | .29 | 51,781 |
| 2012-07-02 | Gadicke Ansbert (10% Owner) | Sale | 80,348 | .29 | 23,300 |
| 2012-06-28 | Mpm Bioventures Iii Gp L.p. (10% Owner) | Sale | 19,500 | .29 | 5,655 |
| 2012-06-28 | Gadicke Ansbert (10% Owner) | Sale | 19,500 | .29 | 5,655 |
| 2012-06-19 | Mpm Bioventures Iii Gp L.p. (10% Owner) | Sale | 12,000 | .29 | 3,479 |
| 2012-06-19 | Gadicke Ansbert (10% Owner) | Sale | 12,000 | .29 | 3,479 |
| 2012-06-15 | Mpm Bioventures Iii Gp L.p. (10% Owner) | Sale | 1,450 | .29 | 420 |
| 2012-06-15 | Gadicke Ansbert (10% Owner) | Sale | 1,450 | .29 | 420 |
| 2012-06-06 | Mpm Bioventures Iii Gp L.p. (10% Owner) | Sale | 8,400 | .29 | 2,436 |
| 2012-06-06 | Gadicke Ansbert (10% Owner) | Sale | 8,400 | .29 | 2,436 |
| 2012-06-05 | Mpm Bioventures Iii Gp L.p. (10% Owner) | Sale | 29,555 | .29 | 8,570 |
| 2012-06-05 | Gadicke Ansbert (10% Owner) | Sale | 29,555 | .29 | 8,570 |
| 2012-05-31 | Wheeler Kurt (10% Owner) | Sale | 29,850 | .30 | 8,955 |
| 2012-05-31 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 29,850 | .30 | 8,955 |
| 2012-05-30 | Wheeler Kurt (10% Owner) | Sale | 51,007 | .30 | 15,302 |
| 2012-05-30 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 51,007 | .30 | 15,302 |
| 2012-05-29 | Wheeler Kurt (10% Owner) | Sale | 15,300 | .30 | 4,620 |
| 2012-05-29 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 15,300 | .30 | 4,620 |
| 2012-05-25 | Wheeler Kurt (10% Owner) | Sale | 293,015 | .30 | 87,904 |
| 2012-05-25 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 293,015 | .30 | 87,904 |
| 2012-05-23 | Wheeler Kurt (10% Owner) | Sale | 135,250 | .30 | 40,575 |
| 2012-05-23 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 135,250 | .30 | 40,575 |
| 2012-05-22 | Wheeler Kurt (10% Owner) | Sale | 287,000 | .30 | 86,961 |
| 2012-05-22 | Mpm Bioventures Iii Llc (10% Owner) | Sale | 287,000 | .30 | 86,961 |
| 2012-01-03 | Nguyen Tran (SVP and CFO) | Sale | 3,300 | .48 | 1,574 |
| 2012-01-03 | Dorsey Brian (SVP, Technical Operations) | Sale | 9,000 | .48 | 4,293 |
| 2012-01-03 | Onaitis Matthew (SVP, General Counsel) | Sale | 9,000 | .48 | 4,293 |
| 2012-01-03 | Pascoe Richard W (President and CEO) | Sale | 18,750 | .48 | 8,943 |
| 2011-10-03 | Mast Erle T (Director) | Sale | 5,000 | .85 | 4,260 |
| 2011-08-15 | Mast Erle T (Director) | Sale | 5,000 | 1.11 | 5,560 |
| 2011-07-01 | Mast Erle T (Director) | Sale | 5,000 | 2.13 | 10,634 |
| 2011-06-10 | Pascoe Richard W (President and CEO) | Buy | 11,100 | 2.25 | 24,941 |
| 2011-05-16 | Mast Erle T (Director) | Sale | 5,000 | 2.65 | 13,245 |
| 2011-04-12 | Nguyen Tran (SVP and CFO) | Sale | 3,300 | 2.84 | 9,358 |
| 2011-04-01 | Mast Erle T (Director) | Sale | 5,000 | 2.81 | 14,065 |
| 2011-02-15 | Mast Erle T (Director) | Sale | 10,000 | 3.01 | 30,099 |
| 2011-01-06 | Raser Jeffrey (SVP, Chief Commercial Officer) | Sale | 16,115 | 3.50 | 56,402 |
| 2011-01-03 | Mast Erle T (Director) | Sale | 10,000 | 3.23 | 32,340 |
| 2010-12-02 | Emster Kurt Von (Director) | Sale | 26,000 | 2.78 | 72,306 |
| 2010-12-01 | Dorsey Brian (SVP, Technical Operations) | Sale | 8,468 | 2.68 | 22,728 |
| 2010-12-01 | Onaitis Matthew (SVP, General Counsel) | Sale | 8,468 | 2.68 | 22,728 |
| 2010-12-01 | Cobb Terrell (Director) | Sale | 17,243 | 2.68 | 46,262 |
| 2010-12-01 | Raser Jeffrey (SVP, Chief Commercial Officer) | Sale | 9,718 | 2.68 | 26,063 |
| 2010-12-01 | Pascoe Richard W (President and CEO) | Sale | 13,781 | 2.68 | 36,974 |
| 2010-12-01 | Eagle Michael L (Director) | Sale | 24,900 | 2.68 | 66,806 |
| 2010-12-01 | Wiggans Thomas G (Director) | Sale | 30,163 | 2.68 | 80,927 |
| 2010-12-01 | Hale David F (Director) | Sale | 107,893 | 2.68 | 289,584 |
| 2010-09-22 | Cobb Terrell (Director) | Sale | 11,282 | 4.24 | 47,801 |
| 2010-09-15 | Nguyen Tran (Vice President and CFO) | Buy | 2,500 | 3.89 | 9,725 |
| 2010-09-01 | Dorsey Brian (SVP, Technical Operations) | Sale | 3,000 | 4.27 | 12,809 |
| 2010-09-01 | Dorsey Brian (SVP, Technical Operations) | Option Ex | 3,000 | 1.23 | 3,690 |
| 2010-08-25 | Dorsey Brian (SVP, Technical Operations) | Sale | 5,000 | 4.99 | 24,950 |
| 2010-08-25 | Dorsey Brian (SVP, Technical Operations) | Option Ex | 5,000 | 1.23 | 6,150 |
| 2010-08-10 | Dorsey Brian (SVP, Technical Operations) | Sale | 3,000 | 3.99 | 11,970 |
| 2010-08-10 | Dorsey Brian (SVP, Technical Operations) | Option Ex | 3,000 | 1.23 | 3,690 |
| 2010-07-15 | Dorsey Brian (SVP, Technical Operations) | Sale | 3,000 | 3.99 | 11,970 |
| 2010-07-15 | Dorsey Brian (SVP, Technical Operations) | Option Ex | 3,000 | 1.23 | 3,690 |
| 2010-06-24 | Dorsey Brian (SVP, Technical Operations) | Sale | 9,000 | 4.48 | 40,347 |
| 2010-06-24 | Dorsey Brian (SVP, Technical Operations) | Option Ex | 9,000 | 1.23 | 11,070 |
| 2010-06-24 | Raser Jeffrey (SVP, Chief Commercial Officer) | Sale | 15,000 | 4.67 | 70,050 |
Insider trading activities including stock purchases, stock sales, and option exercises of SOMX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Somaxon Pharmaceuticals, Inc. (symbol SOMX, CIK number 1339455) see the Securities and Exchange Commission (SEC) website.